Literature DB >> 8482976

Cerebral glucose metabolism and striatal 18F-dopa uptake by PET in cases of chorea with or without dementia.

M Otsuka1, Y Ichiya, Y Kuwabara, S Hosokawa, M Sasaki, T Fukumura, K Masuda, I Goto, M Kato.   

Abstract

Cerebral glucose metabolism was studied by positron emission tomography with [18F]fluorodeoxyglucose in 12 patients with chorea due to different underlying diseases. The striatal 18F-dopa uptake was also studied with 6-L-[18F]fluorodopa in 6 of them. Five of them were diagnosed as Huntington's disease two were as 'sporadic progressive chorea and dementia' with characteristic symptoms and signs of Huntington's disease but no family histories, two were as choreoacanthocytosis, and two had hemichorea caused by suspected vascular lesions in the contralateral striatum revealed by MRI. Caudate and putaminal glucose metabolism decreased in chorea compared to the controls. Hemichorea showed decreased glucose metabolism only in the contralateral striatum. Moreover the glucose metabolism decreased in demented each 7 patients in the frontal, temporal and parietal cortices as well as in the striatum. The caudate and putaminal 18F-dopa uptake in patients with chorea showed no difference with that in the controls. The pathogenetic mechanism of chorea may involve decreased glucose metabolism and normal presynaptic dopaminergic activity in the striatum, and that of the demented state in chorea may also involve an additional decrease of the glucose metabolism in the frontal, temporal and parietal cortices.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482976     DOI: 10.1016/0022-510x(93)90218-n

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Non-ketotic hyperglycaemic chorea: a SPECT study.

Authors:  M H Chang; J Y Li; S R Lee; C Y Men
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

2.  Striking lack of visualization of striatum on 18F-FDG brain PET in chorea-acanthocytosis.

Authors:  Diego Alfonso López-Mora; Valle Camacho; Alejandro Fernández; Esther Granell; Ignasi Carrió
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-15       Impact factor: 9.236

Review 3.  Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease.

Authors:  Federica Agosta; Daniele Altomare; Cristina Festari; Stefania Orini; Federica Gandolfo; Marina Boccardi; Javier Arbizu; Femke Bouwman; Alexander Drzezga; Peter Nestor; Flavio Nobili; Zuzana Walker; Marco Pagani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-01       Impact factor: 9.236

4.  A Case of Genetically Confirmed Chorea-Acanthocytosis: Brain [18F]FDG-PET and [18F]FP-CIT-PET Findings.

Authors:  Jong-Mok Lee; Chae Moon Hong; Ho-Sung Ryu
Journal:  Ann Indian Acad Neurol       Date:  2019-12-18       Impact factor: 1.383

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.